Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.
about
Mechanisms and applications of interleukins in cancer immunotherapy.Phenotypically distinct helper NK cells are required for gp96-mediated anti-tumor immunity.Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines.Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection.HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer.Immunogenic Effect of Hyperthermia on Enhancing Radiotherapeutic Efficacy
P2860
Heat shock protein vaccination and directed IL-2 therapy amplify tumor immunity rapidly following bone marrow transplantation in mice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Heat shock protein vaccination ...... arrow transplantation in mice.
@ast
Heat shock protein vaccination ...... arrow transplantation in mice.
@en
Heat shock protein vaccination ...... arrow transplantation in mice.
@nl
type
label
Heat shock protein vaccination ...... arrow transplantation in mice.
@ast
Heat shock protein vaccination ...... arrow transplantation in mice.
@en
Heat shock protein vaccination ...... arrow transplantation in mice.
@nl
prefLabel
Heat shock protein vaccination ...... arrow transplantation in mice.
@ast
Heat shock protein vaccination ...... arrow transplantation in mice.
@en
Heat shock protein vaccination ...... arrow transplantation in mice.
@nl
P2093
P2860
P1433
P1476
Heat shock protein vaccination ...... arrow transplantation in mice.
@en
P2093
Eckhard R Podack
Michael J Dee
Robert B Levy
Robert G Newman
Thomas R Malek
P2860
P304
P356
10.1182/BLOOD-2013-08-520775
P407
P577
2014-03-31T00:00:00Z